| Name | Title | Contact Details |
|---|
Tetramed is a Niles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cannuflow Incorporated is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ARC Devices is a wireless, non-contact, vital signs and medical devices monitor innovator. Founded in 2012 we create world class vital signs monitors and medical devices for clinical professionals as well as responsible consumers; ensuring that you recieve the latest benefits of the personal health-care revolution. With an ever increasing awareness of health care becoming an essential element of modern life we take pride in our reputation for excellence and originality, maintaining the highest industry standards in both our products and our consumer service. By focusing on creativity, imagination, and invention we push the boundaries of technology to meet your needs in an increasingly fast paced, health concious, world. From family friendly, non-contact thermometers, to futuristic vital signs monitors, we create easy-to-use precision instruments which are small enough to fit in the palm of your hand. As the global medical revolution gains pace the team at Arc Designs continues to innovate and take the first leaps towards the next generation of personalized healthcare. We believe in a better future and so we look to the stars to improve the ground on which you stand.
TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.
Biorez is dedicated to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We have developed the BioBrace™ scaffold, a new implant technology to reinforce tendon and ligament repairs and to facilitate tissue regeneration. Through our proprietary open porous architecture, and use of biomaterials, the BioBrace™ has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state. Early pre-clinical work suggests the BioBrace will deliver on the promise of a superior tissue scaffold to accelerate rehabilitation, regenerate functional tissue, and improve overall outcomes. Biorez is a VC-backed startup located in New Haven, CT.